The Team

The Discovery Team

We have a small, dedicated, cross-functional team and feel strongly about maintaining scientific integrity. The Mercaptor espirit de corps is rooted in mutual respect and trust that has been cultivated over years of shared effort. We all wear many hats – proudly.

The Board

Mercaptor has been fortunate in the composition of its Board of Directors. Relying initially on two hapless founders, Mercaptor was mercifully introduced by friends to our board members. Possessed of extraordinary and fortuitously-apt skills for an endeavor like Mercaptor their accession to the Board provided encouragement to a team in need of a little validation and added decades of applicable experience to Mercaptor’s managerial team.

Erich Sager, MBA

Erich Sager is an international private banking executive and has been a strong supporter of biopharma companies over the past 20 years. Currently Chairman at CellProtect

Read More »

The Advisory Board

A tiny company, a remarkable discovery, and a lot to do.  Mercaptor presented some interesting problems.  And not the kind familiar to scientists.  One such problem was in engaging the world and communicating our story; another, related, but a more existential problem, was in finding money.  We needed help.  People to show us a way, without ignoring some founding principles:  Avoid reliance on the sclerotic, inefficient approach to drug development common in the modern pharmaceutical industry.

Dr. Adriano Aguzzi, MD, PhD

Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of Mercaptor’s Scientific Advisory Board (SAB). Dr. Aguzzi is a world-renowned neuropathologist, whose research has garnered

Read More »